Back to search

National and Kapodistrian University of Athens

Ο ρόλος των μικροκυστιδίων στα οξέα στεφανιαία σύνδρομα: συσχέτιση με τη φλεγμονή, την πήξη και την ενδοθηλιακή λειτουργία

Abstract

dc:description

Introduction: Circulating microvesicles (MV), which are derived from blood cells and endothelial cells, have been considered surrogate markers of atherosclerosis. However, their role in acute coronary syndromes (ACS) has not been fully elucidated yet, while most of the data stem from the apoptotic, phosphatidylserine positive (PS+) microvesicles. The present study aims to examine the role of the association of circulating MVs with ACS pathophysiology and to compare the roles of apoptotic (PS+) and non-apoptotic (PS-) circulating microvesicles in patients with ACS. Methods: One hundred and fifty-three patients (n=153) were included in the study; 49 patients with ST-elevation myocardial infarction (STEMI), 35 with non-STEMI (NSTEMI), 38 with unstable angina, 15 with stable coronary artery disease and 16 control individuals. Flow cytometry analysis was used to quantify circulating apoptotic/non-apoptotic (phospatidyloserine+/phospatidyloserine-) endothelial cell (EMV), red blood cell (RMV) and platelet (PMV) derived MV. Flow-mediated dilatation (FMD) of the brachial artery was assessed by ultrasound to estimate endothelial function. The inflammatory profile was assessed by serum C-reactive protein (hsCRP) and ST-2 levels. The plasma thrombotic profile was assessed by measurement of the fibrinogen and D-dimers. The extent of myocardial damage was estimated by the peak high sensitivity troponin- I levels. The patients underwent coronary angiography and/or angioplasty, where indicated, according to the guidelines. The angiographic data and GENSINI scores were recorded and calculated. The patients were followed-up for 18 months. Results: Apoptotic MV were increased in patients with ACS (EMV, P=2.32x10-9; RMV, P=.0019; PMV, P=0.01), whereas but no similar increase was noted for the non-apoptotic MV. Hierarchical clustering of the total population of ACS patients (n=122) by circulating levels of phospatidyloserine+ EMV, RMV and PMV identified two discreet clusters of patients without any differences in traditional risk factors, but significant differences in brachial FMD (5.2% (2.5) vs. 4.1% (2.3), P<.05) that remained significant after adjustment for co-variates. The prevalence of STEMI, a surrogate for plaque rupture and vessel thrombotic occlusion, was significantly higher in the patient cluster with impaired endothelial function, which was the cluster with the higher levels of apoptotic MV (60% vs 32%, P=.016, adjusted odds ratio for STEMI, 3.041, 95%CI, 1.160 to 7.968, p=.024). Moreover, the patients with higher levels of PS+MV had a higher inflammatory status and a higher burden of atherosclerotic coronary lesions. On the contrary, the levels of PS-MV were negatively correlated with the levels of the inflammatory biomarkers and the extent of myocardial damage. Both PS+ and PS-MV were negatively correlated with the levels of fibrinogen. The patients with “higher levels of non apoptotic EMV” had decreased prevalence for death and or readmissions (19.6% vs 39,6%) and a longer event-free survival (15.8 vs 13.7 months) compared to patients with «lower levels of non-apoptotic EMV» (p=0.0310). Additionally, patients with a “profile of non-apoptotiv EMV” had a decreased prevalence for the cumulative event of death and or readmission for cardiovascular causes (9.5 vs 34.6%) and a longer event-free survival (17.3 vs 14 months) compared to patients with a “profile of apoptotic EMV” (p=0.022). The findings regarding RMV were similar. Conclusions: The present study showed, for the first time to the best of our knowledge, the differences between the apoptotic and non-apoptotic microvesicles in patients with Acute Coronary Syndromes. Previously, microvesicles had been linked to detrimental effects in patients with atherosclerosis. The present study showed that only the subpopulation of apoptotic microvesicles seems to be linked to the adverse cardiovascular effects seen in patients with atherosclerosis. On the contrary, non-apoptotic microvesicles seem to exert a protective role in these patients.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2022

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Zacharia, Effimia-Maria
  • Ζαχαρία, Ευφημία-Μαρία

Subjects

dc:subject × 37

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/52152

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Zacharia, Effimia-Maria; Ζαχαρία, Ευφημία-Μαρία. Ο ρόλος των μικροκυστιδίων στα οξέα στεφανιαία σύνδρομα: συσχέτιση με τη φλεγμονή, την πήξη και την ενδοθηλιακή λειτουργία. National and Kapodistrian University of Athens, 2022. http://hdl.handle.net/10442/hedi/52152